CN Stock MarketDetailed Quotes

002603 Shijiazhuang Yiling Pharmaceutical

Watchlist
  • 20.12
  • -0.07-0.35%
Trading Mar 29 13:37 CST
33.61BMarket Cap12.42P/E (TTM)

Shijiazhuang Yiling Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
(Q9)Sep 30, 2021
(Q6)Jun 30, 2021
Total operating revenue
7.91%8.57B
21.99%6.79B
44.56%3.93B
23.88%12.53B
-2.04%7.95B
-5.59%5.57B
-25.80%2.72B
15.19%10.12B
25.81%8.11B
31.41%5.9B
Operating revenue
7.91%8.57B
21.99%6.79B
44.56%3.93B
23.88%12.53B
-2.04%7.95B
-5.59%5.57B
-25.80%2.72B
15.19%10.12B
25.81%8.11B
31.41%5.9B
Other operating revenue
----
-64.36%2.85M
----
113.13%13.04M
----
156.01%7.99M
----
-27.35%6.12M
----
-21.29%3.12M
Total operating cost
5.70%6.58B
14.62%4.9B
16.31%2.49B
12.93%9.67B
-7.39%6.22B
-10.74%4.28B
-24.98%2.14B
16.57%8.56B
27.20%6.72B
30.81%4.79B
Operating cost
10.82%3.34B
23.65%2.6B
29.96%1.38B
23.35%4.54B
3.89%3.02B
1.03%2.1B
-19.08%1.06B
18.04%3.68B
19.17%2.9B
22.60%2.08B
Operating tax surcharges
-11.46%110.22M
-7.89%78.69M
-4.21%46.12M
46.99%203.45M
16.40%124.49M
9.96%85.43M
-10.24%48.14M
1.56%138.41M
17.03%106.95M
21.99%77.69M
Operating expense
-3.74%2.09B
3.06%1.52B
-2.10%731.73M
-5.10%3.26B
-22.34%2.17B
-27.71%1.48B
-36.84%747.42M
13.14%3.43B
36.48%2.8B
41.24%2.05B
Administration expense
21.97%430.36M
28.06%294.89M
39.37%167.48M
23.23%612.22M
1.65%352.84M
4.50%230.27M
4.64%120.17M
24.10%496.82M
8.65%347.1M
9.04%220.35M
Financial expense
80.26%9.45M
-41.13%4.73M
-91.07%495.21K
15.02%19.92M
-80.78%5.24M
-13.90%8.04M
116.41%5.55M
1,042.94%17.32M
791.54%27.28M
1,073.74%9.34M
-Interest expense (Financial expense)
12.91%25.87M
-0.55%15.8M
-26.68%6.04M
-0.53%33.8M
-43.71%22.91M
-16.53%15.89M
35.73%8.24M
209.93%33.97M
378.04%40.71M
177.07%19.03M
-Interest Income (Financial expense)
7.74%-17.16M
-17.67%-11.73M
-127.02%-8.2M
36.93%-12.9M
-13.80%-18.6M
16.01%-9.97M
20.83%-3.61M
-44.65%-20.45M
-30.05%-16.34M
-68.39%-11.87M
Research and development
7.62%593.71M
7.64%402.61M
4.29%164.84M
30.28%1.03B
2.62%551.68M
4.03%374.04M
-15.73%158.06M
21.05%792.16M
37.96%537.59M
41.53%359.56M
Credit Impairment Loss
-156.05%-10.49M
-37.89%-2.74M
605.36%1.57M
55.11%-16.93M
19.44%-4.1M
11.84%-1.99M
-141.80%-309.8K
-86.24%-37.71M
-120.79%-5.08M
-36.25%-2.25M
Asset Impairment Loss
-528.23%-15.92M
-151.78%-15.92M
---14.54M
-278.74%-108.43M
---2.53M
---6.32M
----
50.77%-28.63M
----
----
Other net revenue
310.88%130.8M
274.68%51.73M
559.33%11.25M
-403.68%-36.4M
-44.63%31.83M
-69.44%13.81M
-82.61%1.71M
864.14%11.99M
28.93%57.49M
49.62%45.18M
Fair value change income
3,200.46%44.43M
2,586.99%27.7M
2,279.16%10.56M
910.90%18.73M
0.00%1.35M
15.04%1.03M
-80.78%443.75K
-64.56%1.85M
-55.98%1.35M
-91.27%896.09K
Invest income
94.38%-389.59K
149.87%2.56M
-13.01%-4.38M
69.56%-7.23M
-371.14%-6.93M
-377.43%-5.14M
-1,203.62%-3.87M
-197.44%-23.75M
-87.82%2.56M
-66.96%1.85M
-Including: Investment income associates
---10.01K
---9.85K
----
---2.99K
----
----
----
----
----
----
Asset deal income
49.88%-1.49M
63.18%-951.69K
71.35%-128.28K
-23.64%-3.11M
-284.25%-2.96M
-267.27%-2.58M
66.27%-447.7K
-1,902.33%-2.52M
-97.97%-771.61K
-107.49%-703.8K
Other revenue
143.85%114.65M
42.60%41.07M
208.31%18.17M
-21.58%80.56M
-20.91%47.01M
-36.53%28.8M
-23.87%5.89M
118.17%102.74M
155.92%59.45M
178.21%45.39M
Operating profit
21.25%2.13B
48.93%1.94B
149.70%1.46B
80.33%2.83B
21.02%1.76B
13.39%1.3B
-29.29%583.45M
9.11%1.57B
19.86%1.45B
34.62%1.15B
Add:Non operating Income
-10.37%3.86M
102.52%2.76M
113.72%1.58M
-23.37%8.37M
-50.36%4.31M
-69.39%1.36M
-56.65%740.25K
980.48%10.92M
404.22%8.68M
348.50%4.45M
Less:Non operating expense
-51.71%26.48M
-77.36%7.73M
-84.80%2.26M
118.02%57.28M
314.46%54.85M
210.17%34.13M
502.24%14.9M
58.51%26.27M
44.91%13.23M
64.08%11M
Total profit
23.52%2.11B
52.38%1.93B
155.79%1.46B
78.97%2.78B
17.91%1.71B
11.17%1.27B
-30.95%569.3M
9.23%1.55B
20.22%1.45B
34.75%1.14B
Less:Income tax cost
20.19%352.15M
49.14%330.34M
196.95%254.75M
99.84%423.82M
31.20%292.99M
25.13%221.5M
-42.57%85.79M
2.19%212.09M
18.74%223.32M
32.44%177.01M
Net profit
24.21%1.75B
53.07%1.6B
148.48%1.2B
75.67%2.36B
15.48%1.41B
8.61%1.05B
-28.37%483.51M
10.43%1.34B
20.50%1.22B
35.19%964.24M
Net profit from continuing operation
24.21%1.75B
53.07%1.6B
148.48%1.2B
75.67%2.36B
15.48%1.41B
8.61%1.05B
-28.37%483.51M
10.43%1.34B
20.50%1.22B
35.19%964.24M
Less:Minority Profit
-115.41%-4.75M
-127.02%-2.97M
-33.20%-1.08M
-124.08%-4.98M
-153.12%-2.2M
-1,137.88%-1.31M
-327.07%-808.96K
41.59%-2.22M
35.62%-870.75K
112.94%126.08K
Net profit of parent company owners
24.35%1.76B
53.16%1.61B
148.29%1.2B
75.75%2.36B
15.58%1.41B
8.76%1.05B
-28.22%484.32M
10.27%1.34B
20.43%1.22B
34.99%964.12M
Earning per share
Basic earning per share
24.36%1.0527
53.17%0.9613
148.28%0.72
75.75%1.4137
15.58%0.8465
8.75%0.6276
-28.18%0.29
10.27%0.8044
20.42%0.7324
34.99%0.5771
Diluted earning per share
24.36%1.0527
53.17%0.9613
148.28%0.72
75.75%1.4137
15.58%0.8465
8.75%0.6276
-28.18%0.29
10.27%0.8044
20.42%0.7324
34.99%0.5771
Other composite income
-60.16%894.04K
-7.73%993.76K
308.67%344.14K
495.75%2.49M
1,580.59%2.24M
690.49%1.08M
-168.16%-164.92K
87.92%-629.84K
105.71%133.54K
-128.97%-182.39K
Other composite income of parent company owners
-60.16%894.04K
-7.73%993.76K
308.67%344.14K
495.75%2.49M
1,580.59%2.24M
690.49%1.08M
-168.16%-164.92K
87.92%-629.84K
105.71%133.54K
-128.97%-182.39K
Total composite income
24.07%1.75B
53.01%1.6B
148.64%1.2B
75.94%2.36B
15.65%1.41B
8.74%1.05B
-28.42%483.34M
10.85%1.34B
20.79%1.22B
35.04%964.06M
Total composite income of parent company owners
24.21%1.76B
53.10%1.61B
148.45%1.2B
76.02%2.36B
15.75%1.42B
8.89%1.05B
-28.27%484.15M
10.69%1.34B
20.72%1.22B
34.84%963.93M
Total composite income of minority owners
-115.41%-4.75M
-127.02%-2.97M
-33.20%-1.08M
-124.08%-4.98M
-153.12%-2.2M
-1,137.88%-1.31M
-327.07%-808.96K
41.59%-2.22M
35.62%-870.75K
112.94%126.08K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Zhongqin Wanxin Certified Public Accountants (Special General Partnership)
--
--
--
Zhongqin Wanxin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021(Q9)Sep 30, 2021(Q6)Jun 30, 2021
Total operating revenue 7.91%8.57B21.99%6.79B44.56%3.93B23.88%12.53B-2.04%7.95B-5.59%5.57B-25.80%2.72B15.19%10.12B25.81%8.11B31.41%5.9B
Operating revenue 7.91%8.57B21.99%6.79B44.56%3.93B23.88%12.53B-2.04%7.95B-5.59%5.57B-25.80%2.72B15.19%10.12B25.81%8.11B31.41%5.9B
Other operating revenue -----64.36%2.85M----113.13%13.04M----156.01%7.99M-----27.35%6.12M-----21.29%3.12M
Total operating cost 5.70%6.58B14.62%4.9B16.31%2.49B12.93%9.67B-7.39%6.22B-10.74%4.28B-24.98%2.14B16.57%8.56B27.20%6.72B30.81%4.79B
Operating cost 10.82%3.34B23.65%2.6B29.96%1.38B23.35%4.54B3.89%3.02B1.03%2.1B-19.08%1.06B18.04%3.68B19.17%2.9B22.60%2.08B
Operating tax surcharges -11.46%110.22M-7.89%78.69M-4.21%46.12M46.99%203.45M16.40%124.49M9.96%85.43M-10.24%48.14M1.56%138.41M17.03%106.95M21.99%77.69M
Operating expense -3.74%2.09B3.06%1.52B-2.10%731.73M-5.10%3.26B-22.34%2.17B-27.71%1.48B-36.84%747.42M13.14%3.43B36.48%2.8B41.24%2.05B
Administration expense 21.97%430.36M28.06%294.89M39.37%167.48M23.23%612.22M1.65%352.84M4.50%230.27M4.64%120.17M24.10%496.82M8.65%347.1M9.04%220.35M
Financial expense 80.26%9.45M-41.13%4.73M-91.07%495.21K15.02%19.92M-80.78%5.24M-13.90%8.04M116.41%5.55M1,042.94%17.32M791.54%27.28M1,073.74%9.34M
-Interest expense (Financial expense) 12.91%25.87M-0.55%15.8M-26.68%6.04M-0.53%33.8M-43.71%22.91M-16.53%15.89M35.73%8.24M209.93%33.97M378.04%40.71M177.07%19.03M
-Interest Income (Financial expense) 7.74%-17.16M-17.67%-11.73M-127.02%-8.2M36.93%-12.9M-13.80%-18.6M16.01%-9.97M20.83%-3.61M-44.65%-20.45M-30.05%-16.34M-68.39%-11.87M
Research and development 7.62%593.71M7.64%402.61M4.29%164.84M30.28%1.03B2.62%551.68M4.03%374.04M-15.73%158.06M21.05%792.16M37.96%537.59M41.53%359.56M
Credit Impairment Loss -156.05%-10.49M-37.89%-2.74M605.36%1.57M55.11%-16.93M19.44%-4.1M11.84%-1.99M-141.80%-309.8K-86.24%-37.71M-120.79%-5.08M-36.25%-2.25M
Asset Impairment Loss -528.23%-15.92M-151.78%-15.92M---14.54M-278.74%-108.43M---2.53M---6.32M----50.77%-28.63M--------
Other net revenue 310.88%130.8M274.68%51.73M559.33%11.25M-403.68%-36.4M-44.63%31.83M-69.44%13.81M-82.61%1.71M864.14%11.99M28.93%57.49M49.62%45.18M
Fair value change income 3,200.46%44.43M2,586.99%27.7M2,279.16%10.56M910.90%18.73M0.00%1.35M15.04%1.03M-80.78%443.75K-64.56%1.85M-55.98%1.35M-91.27%896.09K
Invest income 94.38%-389.59K149.87%2.56M-13.01%-4.38M69.56%-7.23M-371.14%-6.93M-377.43%-5.14M-1,203.62%-3.87M-197.44%-23.75M-87.82%2.56M-66.96%1.85M
-Including: Investment income associates ---10.01K---9.85K-------2.99K------------------------
Asset deal income 49.88%-1.49M63.18%-951.69K71.35%-128.28K-23.64%-3.11M-284.25%-2.96M-267.27%-2.58M66.27%-447.7K-1,902.33%-2.52M-97.97%-771.61K-107.49%-703.8K
Other revenue 143.85%114.65M42.60%41.07M208.31%18.17M-21.58%80.56M-20.91%47.01M-36.53%28.8M-23.87%5.89M118.17%102.74M155.92%59.45M178.21%45.39M
Operating profit 21.25%2.13B48.93%1.94B149.70%1.46B80.33%2.83B21.02%1.76B13.39%1.3B-29.29%583.45M9.11%1.57B19.86%1.45B34.62%1.15B
Add:Non operating Income -10.37%3.86M102.52%2.76M113.72%1.58M-23.37%8.37M-50.36%4.31M-69.39%1.36M-56.65%740.25K980.48%10.92M404.22%8.68M348.50%4.45M
Less:Non operating expense -51.71%26.48M-77.36%7.73M-84.80%2.26M118.02%57.28M314.46%54.85M210.17%34.13M502.24%14.9M58.51%26.27M44.91%13.23M64.08%11M
Total profit 23.52%2.11B52.38%1.93B155.79%1.46B78.97%2.78B17.91%1.71B11.17%1.27B-30.95%569.3M9.23%1.55B20.22%1.45B34.75%1.14B
Less:Income tax cost 20.19%352.15M49.14%330.34M196.95%254.75M99.84%423.82M31.20%292.99M25.13%221.5M-42.57%85.79M2.19%212.09M18.74%223.32M32.44%177.01M
Net profit 24.21%1.75B53.07%1.6B148.48%1.2B75.67%2.36B15.48%1.41B8.61%1.05B-28.37%483.51M10.43%1.34B20.50%1.22B35.19%964.24M
Net profit from continuing operation 24.21%1.75B53.07%1.6B148.48%1.2B75.67%2.36B15.48%1.41B8.61%1.05B-28.37%483.51M10.43%1.34B20.50%1.22B35.19%964.24M
Less:Minority Profit -115.41%-4.75M-127.02%-2.97M-33.20%-1.08M-124.08%-4.98M-153.12%-2.2M-1,137.88%-1.31M-327.07%-808.96K41.59%-2.22M35.62%-870.75K112.94%126.08K
Net profit of parent company owners 24.35%1.76B53.16%1.61B148.29%1.2B75.75%2.36B15.58%1.41B8.76%1.05B-28.22%484.32M10.27%1.34B20.43%1.22B34.99%964.12M
Earning per share
Basic earning per share 24.36%1.052753.17%0.9613148.28%0.7275.75%1.413715.58%0.84658.75%0.6276-28.18%0.2910.27%0.804420.42%0.732434.99%0.5771
Diluted earning per share 24.36%1.052753.17%0.9613148.28%0.7275.75%1.413715.58%0.84658.75%0.6276-28.18%0.2910.27%0.804420.42%0.732434.99%0.5771
Other composite income -60.16%894.04K-7.73%993.76K308.67%344.14K495.75%2.49M1,580.59%2.24M690.49%1.08M-168.16%-164.92K87.92%-629.84K105.71%133.54K-128.97%-182.39K
Other composite income of parent company owners -60.16%894.04K-7.73%993.76K308.67%344.14K495.75%2.49M1,580.59%2.24M690.49%1.08M-168.16%-164.92K87.92%-629.84K105.71%133.54K-128.97%-182.39K
Total composite income 24.07%1.75B53.01%1.6B148.64%1.2B75.94%2.36B15.65%1.41B8.74%1.05B-28.42%483.34M10.85%1.34B20.79%1.22B35.04%964.06M
Total composite income of parent company owners 24.21%1.76B53.10%1.61B148.45%1.2B76.02%2.36B15.75%1.42B8.89%1.05B-28.27%484.15M10.69%1.34B20.72%1.22B34.84%963.93M
Total composite income of minority owners -115.41%-4.75M-127.02%-2.97M-33.20%-1.08M-124.08%-4.98M-153.12%-2.2M-1,137.88%-1.31M-327.07%-808.96K41.59%-2.22M35.62%-870.75K112.94%126.08K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Zhongqin Wanxin Certified Public Accountants (Special General Partnership)------Zhongqin Wanxin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg